CBM2

News & Events

Dr. Soper to Give Distinguished Professor Lecture

University Foundation Distinguished Professor Steven Soper will present “The War Against Cancer: The Role of Engineers and Scientists” at 5:30 p.m. Wednesday, Oct. 24, in the Summerfield Room of the Adams Alumni Center. Read More

KU Hosts ”How to Make It and Use It” Microfluidic Workshop 2018

The third annual “How to Make It and Use It” Microfluidic Workshop, presented by the Center of BioModular Multiscale Systems for Precision Medicine, was hosted this year at the University of Kansas August 1-3, 2018. Twenty participants came to KU from Arkansas, Kansas, Louisiana, Missouri, and Oklahoma to learn how to fabricate a microfluidic device, and how the process of making and using it could be applied to many areas of research. Read More

CBM2 Members attend Gordon Research Conference

Three members of the CBM 2 team attended the Liquid Biopsy for Cancer: Circulating Tumor Cells, ctDNA and Extracellular Vesicles session of the Gordon Research Conference, August 5–10, 2018 at Mount Holyoke College in Massachusetts. Read More

NIH/NIBIB Website Highlights KU Research

University of Kansas researchers' development of a microfluidic device to diagnose and monitor multiple myeloma was highlighted in an article on the National Institute of Biomedical Imaging and Bioengineering (NIBIB) website July 18, 2018. Read More

Prof. Soper gives talk at Next Generation Dx Summit

Prof. Steven A. Soper presented a talk August 20, 2018 at the Next Generation Dx Summit in Washington, DC. His talk was titled, “New Tools for Liquid Biopsies: Microfluidics for the Efficient Isolation of Circulating Leukemia and Myeloma Cells.”

New Science Facilities Usher in New Era, Learning Opportunities

The Integrated Science Building at the University of Kansas will be a boon to faculty and students in the School of Engineering, officials say — and serve as a crown jewel that attracts innovators and collaborators from the Midwest and beyond. Read More

Chancellor Hails ISB as 'Giant Leap Forward' for KU Science Facilities

KU's new Integrated Sciences Building (ISB) was recently highlighted in Chancellor Douglas Girod's twice-monthly Monday Message as one of the more exciting new campus facilities, which has the potential to improve KU’s standing in myriad ways. Read More

Steven Soper Gives Talk at University of Notre Dame

“New Tools for Liquid Biopsies: Microfluidic Platforms for the Efficient Isolation and Molecular Profiling of Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA) and Nanovesicles (Exosomes)” is the title of the talk that Prof. Steven Soper gave on Monday, July 23, 2018 in South Bend, IN. Read More

Center Director Steve Soper Gives Two Talks on Blood-based Biomarkers

Prof. Steve Soper, director of CBM2, presented “Extracellular Vesicles (EVs) and Cell Free DNA (cfDNA) as Blood-based Biomarkers: Plastic-based Microfluidics for their Enrichment and Analysis” at two Select Biosciences conferences. Read More

Article in GEN Features Dr. Soper’s Work on Microfluidic Device

An article featuring Dr. Steven Soper’s work on creating a microfluidic device that would capture cell-free DNA, exosomes, and circulating tumor cells (CTCs) from liquid biopsy of cancer patients was recently published in Genetic Engineering & Biotechnology News (GEN). Read More

Work Published in 360Dx Highlights KU CBM2 Work

A recent article published by 360Dx highlights work being done by CBM2 researchers titled, “University of Kansas Researchers, BioFluidica Develop Microfluidic-Based Diagnostic for Cancer.” Read More

Panel Composes "Liquid Biopsy" White Paper

Prof. Steven Soper was part of a panel (supported by Cambridge Consultants) that composed a white paper entitled “Liquid Biopsy: Current and Future Utility.”Read More

Soper Group Member Receives Tony B. Academic Travel Award

Kumuditha Ratnayake, post-doctoral researcher from the Soper research group at the University of Kansas, received a Tony B. Academic Travel Award to attend the Society for Laboratory Automation and Screening (SLAS) 2018 International Conference & Exhibition, February 3-7, 2018 in San Diego, CA. Read More

Students from Soper group participate in Undergraduate Research Symposium

The annual Undergraduate Research Symposium at KU celebrates the diversity of undergraduate research and creative activities on campus. Two undergraduate students from the Soper research group, Shalee Mog and Breanna Diaz, presented a poster on Microfluidic-based Analysis of Circulating Tumor Cells at the April 28, 2018 symposium. Read More

Soper Group Participates in Biomedical Sciences Symposium

Members of the Soper group at the University of Kansas participated in the Biomedical Sciences Symposium on April 12, 2018 in KU’s School of Pharmacy. Read More

Student Takes Second Prize in LSU Three Minute Thesis Competition

Congratulations to Zheng Jia, a Ph.D. candidate of Mechanical Engineering under Professor Sunggook Park. He won the second place prize in the LSU Three Minute Thesis (3MT®) Competition with the presentation entitled “DNA Sequencing by Coin-Size Device”. Read More

Soper Group members participate in 2018 Engineering Expo

Members of the Soper group participated in the 2018 Engineering Expo “The Spirit of Innovation” at the University of Kansas, March 2-3, 2018. Over 2,000 area Elementary and Middle School students attended the Expo to explore the world of engineering and science through demonstrations, hands-on activities, and competitions.   Read More

Soper Group Publishes Paper in Integrative Biology

Prof. Steven Soper and Dr. Maggie Witek of the University of Kansas recently published a paper in the journal Integrative Biology titled, “Isolation of circulating plasma cells from blood of patients diagnosed with clonal plasma cell disorders using cell selection microfluidics.”. Read More

Article Features Dr. Soper's Work on Microfluidic Device

An article featuring Dr. Steven Soper’s work on creating a microfluidic device that would capture cell-free DNA, exosomes, and circulating tumor cells (CTCs) from liquid biopsy of cancer patients was recently published in Genetic Engineering & Biotechnology News. Read More

KU Hosts Microfluidic Workshop

The "2018 How to Make It and Use It—A Microfluidic Workshop" will take place August 1–3, 2018 at the University of Kansas Integrated Science Building. Read More

Biotech Startup School@KU Registration Opens

Learn the basics of starting a biotech company at Biotech Startup School@KU. Bring your startup idea or work on a team. Practical advice, mentoring, and networking to move your new biotech venture forward. … Read More

Soper Group Attends ACS Midwest Regional Meeting

The University of Kansas, in Lawrence, KS, hosted the 2017 Midwest Regional Meeting of the American Chemical Society October 18-20, 2017. Members of CBM2’s Soper Research Group presented their research via posters, lectures, and our first ever exhibitor booth. … Read More

CBM2 Researchers Present Work at 2017 microTAS Conference

Several members of CBM2 traveled to Savannah, GA to participate in the 2017 microTAS conference October 22–26, 2017. … Read More

Prof. Steve Soper Speaks at SciX 2017 Conference

Steve Soper, director of CBM2, attended the SciX 2017 conference in Reno, NV October 9-12. His talk, “Electrophoretic Separation of Single Molecules using Thermoplastic Nanocolumns: Applications in Single-Molecule Sequencing,” which discussed nanometer-scale capillary electrophoresis for sequencing single DNA and RNA molecules … Read More

Steve Soper Participated in SelectBio Conferences in San Diego

Steve Soper traveled to San Diego, CA to take part in the Fifth Annual SelectBio Point-of-Care Diagnostics, Global Health & Emerging Viral Diseases World Congress 2017, October 2-4. He ran a short course workshop on October 2nd titled “Basic Principles in Lab-on-a-Chip (LOAC) Technologies for the Study of Circulating Biomarkers: Applications in Liquid Biopsies,” … Read More

KU and UNC Researchers Report New Blood-based Diagnostic for Cancer

Appearing in the journal, Nature Precision Oncology, Prof. Steven A. Soper and Dr. Maggie Witek from the University of Kansas (KU) along with clinical researchers at the University of North Carolina (UNC), report a new liquid biopsy test that searches for circulating tumor cells (CTCs) in the blood of cancer patients. Read More

Professors Publish Paper in Sensors and Actuators B: Chemical

The Center recently published a paper in Sensors and Actuators B: Chemical titled, “Accurate, predictable, repeatable micro-assembly technology for polymer, microfluidic modules.” Read More

CBM2 Developing New Technologies

Cancer patients often must undergo painful surgical biopsies to either diagnose their disease or determine the course of therapy following diagnosis. The Center of BioModular Multiscale Systems for Precision Medicine (CBM2) is developing new technologies that use Liquid Biopsies to make the diagnosis, treatment and monitoring for recurrence for all cancer patients less painful and more efficient than current practice. Read More

Steven A. Soper Lecture at the 2017 Aspen Cancer Conference

Steven A. Soper, Director of the Center of Biomodular Multiscale Systems for Precision Medicine (CBM2), presented a lecture titled, “New Tools for Liquid Biopsies to Enable Precision Medicine,” on July 16, 2017, at the Aspen Cancer Conference. Read More

Visiting Researchers from Korea

Visiting the US are Ms. So Hyun Kim and Ms. Jiae Sur (and doing research in the laboratory of Prof. Steven A. Soper. So Hyun and Jiae are from South Korea and are undergraduates at Ulsan National Institute of Science and Technology (UNIST). UNIST, which was founded in 2009, is one of the four public universities in South Korea dedicated to research in the areas of science and technology. Read More

Prof. Soper Gives Keynote Talks at International Liquid Biopsy Conferences

Prof. Steven Soper, Director of CBM2 was an invited Keynote speaker at the SelectBio Exosomes and Liquid Biopsies Asia Conference in Taipei, Taiwan and the Cambridge Healthtech Institute (CHI) Liquid Biopsy Summit in San Francisco, CA. Read More

CBM2 Publishes Review Paper on CTC Analysis

Prof. Steven Soper, Director of CBM2, published an extensive review paper on microfluidics for the isolation and molecular analysis of Circulating Tumor Cells (DOI: 10.1039/C7CS00016B). Co-authors were Dr. Matt Jackson, Dr. Maggie Witek and Dr. Joyce Kamande. Read More

Chemistry Hosts Alumni Symposium

The KU Chemistry Department hosted an Alumni Symposium May 19-20, 2017 in Lawrence for alumni, faculty, staff and students, commemorating the 10th anniversary of the founding of the Adams Institute. Read More

KU Hosts 2017 EAB Meeting

CBM2 team members from Louisiana State University, Weill Cornell Medical College, and the University of North Carolina traveled to Lawrence, KS to participate in the 2017 all-hands meeting, held on 3/30/17 on the KU campus. Read More

Interview with Dr. Steve Soper on KU Central District Development Project

An interview with Dr. Steven Soper was featured in the KU Central District Summer 2017 Project Update. Read More

Prof. Francis Barany named 2016 NAI Fellow

Prof. Francis Barany, whom is part of the Center leadership team, has been named as a 2016 NAI Fellow. Election as a NAI Fellow is the highest distinction given to academic inventors who have demonstrated a prolific spirit of innovation in creating outstanding inventions that have made an impact on quality of life, economic development, and welfare of society. Read More

Provost recognizes Dr. Soper’s Work.

Dr. Steven Soper’s work with the Kansas Institute for Precision Medicine was recognized in the March 27, 2017 edition of the Provost’s Strong Ties e-newsletter.Read More

Microfluidic Workshop set at UNC

The "2017 How to Make It and Use It – A Microfluidic Workshop" will take place August 3-4, 2017 at the University of North Carolina, Chapel Hill. Check back for details and registration information soon. Read More

Dr. Soper gives keynote at SelectBio World Congress

Dr. Steve Soper gave a keynote speech at the SelectBio World Congress on Circulating Markers, March 20-22, in Boston, MA, for the workshop “New Tools for the Efficient Selection of Liquid Biopsy Markers”. His speech was titled, “New Tools for Liquid Biopsies: Microfluidic Platforms for the Efficient Isolation and Molecular Profiling of Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA) and Nanovesicles (Exosomes).” Read More

Prof. Soper presents at PITTCON

Prof. Steve Soper gave two presentations at PITTCON, March 4-8, 2017 in Chicago, IL titled “New Microfluidic Tools for the Efficient Selection of Circulating Markers used for Managing Cancer-related Diseases,” and “Nanosensors Fabricated in Plastics via NIL for the Detection of Single Molecules.” Read More

Dr. Soper presents at Nortre Dame

Dr. Steve Soper presented at Notre Dame University on March 2, 2017. “New Tools for Liquid Biopsies: Microfluidic Platfoms for the Efficient Isolation and Molecular Profiling of Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA) and Nanovesicles (Exosomes).” Read More

Prof. Soper gives presentation at TRI-CON Conference

Center Director, Professor Steve Soper will give a presentation at the TRI-CON Conference at the Moscone Center in San Francisco, CA, on interrogating DNA damage in CTCs to monitor response to therapy. The technology uses nanofluidic devices emanating from CBM2 to stretch DNA and optically read the chemotherapy-induced DNA damage sites. Read More

Godwin and Soper establishing The Kansas Institute for Precision Medicine

Profs. Andrew Godwin (KUMC) and Steven Soper (KU-L) are establishing the Kansas Institute for Precision Medicine, which seeks to generate mentoring and infrastructure support for young researchers (both basic science and clinical) engaged in discovering new markers for managing an array of complex diseases. Read More

Drs. Keith August and Steven A. Soper Receive Grant from the Midwest Cancer Alliance

Dr. Keith August from Children’s Mercy Hospital and Dr. Steven Soper, Director of CBM2, from the University of Kansas, Lawrence received grant funding from the Midwest Cancer Alliance to support a project focused on detecting disease recurrence in pediatric patients being treated for acute lymphoblastic leukemia, ALL. Read More

CBM2 Calls KU ‘Home’

The team at CBM2 is excited to bring our efforts to The University of Kansas in August 2016. The Center will be based out of the Multidisciplinary Research Building (MRB) in the West District of KU’s Lawrence campus. Read More

Dr Kaufman presents abstract at the Experimental Biology 2016 Meeting

Dr. David Kaufman presented an abstract at the Experimental Biology 2016 Meeting, April 2-6 in San Diego

Abstract: Kaufman, D.G., Chastain, P.D., and Soper, S.A. Digital Determination of Chemotherapeutic Drug-Induced Damage Sites in Single DNA Molecules using Nanofluidic Channels. FASEB J., 2016, 30:51.8. Read More

2016 EAB Meeting

Members of the CBM2 External Advisory Board visited the University of North Carolina, Chapel Hill, Venable Hall, May 19–20, 2016 to view presentations in review of the NIH P41 multisite grant Center, TRDs, Collaborative & Service Projects, and Training & Dissemination. Read More

Dr. Murphy Gives Talk

Dr. Michael Murphy (LSU) gave a talk titled "Toward Repeatable Assembly of Polymer, Modular Multi-scale Fluidic Systems," December 8, 2016 to KU’s Mechanical Engineering department in the ME Conference Room in Learned Hall. Read More

Foundation Professors Focus on Green Chemistry, Cancer Research

Two new Foundation Distinguished Professors in the School of Engineering bring a wealth of private- and public-sector expertise and experience that will help KU broaden its teaching and research ambitions. Read More

Prof. Soper gives presentation at TRI-CON Conference

Center Director, Professor Steve Soper will give a presentation at the TRI-CON Conference at the Moscone Center in San Francisco, CA, on interrogating DNA damage in CTCs to monitor response to therapy. Read More

CBM2 & BioFluidica researchers work on next generation CTC isolation and analysis platform

CBM2 researchers are working with investigators at BioFluidica to build the next generation CTC isolation and analysis platform. Read More

Microfluidic Workshop held in Chapman Hall

The Microfluidic Workshop, which was held in Chapman Hall, June 27–29, offered participants the opportunity to learn about patterning structures across different length scales, nm to μm, and become familiar with a number of important application areas such as microfluidics and nanofluidics for biological/biomedical applications. Read More